Vamil Divan
Stock Analyst at Guggenheim
(4.85)
# 406
Out of 5,133 analysts
962
Total ratings
58.3%
Success rate
13.7%
Average return
Main Sectors:
Stocks Rated by Vamil Divan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ENTX Entera Bio | Maintained: Buy | $11 | $3.24 | +239.51% | 2 | Nov 10, 2026 | |
| ANIP ANI Pharmaceuticals | Reiterated: Buy | $119 → $121 | $67.88 | +78.26% | 24 | Nov 5, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $76 → $66 | $30.60 | +115.69% | 19 | Nov 5, 2026 | |
| AMGN Amgen | Reiterated: Hold | $378 → $435 | $465.15 | -6.48% | 11 | Nov 4, 2026 | |
| PFE Pfizer | Reiterated: Buy | $31 → $33 | $29.24 | +12.86% | 122 | Nov 4, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | $89 → $78 | $51.64 | +51.05% | 33 | Nov 3, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $288 → $322 | $293.31 | +9.78% | 132 | Nov 1, 2026 | |
| INSM Insmed | Reiterated: Buy | $205 → $201 | $116.08 | +73.16% | 20 | Nov 1, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $170 → $171 | $148.72 | +14.98% | 53 | Oct 29, 2026 | |
| ELOX Eloxx Pharmaceuticals | Reiterated: Buy | $43 → $40 | $12.80 | +212.50% | 3 | Oct 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $15.60 | +201.38% | 11 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $287 | $282.13 | +1.73% | 56 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | kr 38.00 | kr 10.82 | +251.20% | 3 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $1.51 | +496.03% | 1 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $5.04 | +118.47% | 11 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $21.74 | +97.79% | 13 | Aug 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $5.66 | +94.35% | 10 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $25 | $3.69 | +578.43% | 9 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $3 | $3.59 | -16.43% | 5 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $10.80 | +38.95% | 5 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $2.86 | +179.72% | 9 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $7 | $1.16 | n/a | 2 | Jul 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.13 | n/a | 4 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €9.00 | €11.02 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $10.90 | n/a | 3 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $26 | $4.15 | n/a | 6 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 13 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $89.90 | n/a | 5 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1,412.05 | n/a | 95 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $15.86 | n/a | 7 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $133.90 | n/a | 15 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $6.97 | n/a | 31 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $27 | $16.48 | n/a | 20 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $46.16 | n/a | 72 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $10 | $1.50 | n/a | 11 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $102.97 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $738 | $920.51 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $40.67 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $135 | $48.10 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $265 | $550.63 | n/a | 1 | May 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $95 | $168.91 | n/a | 30 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 | $26.23 | n/a | 4 | Sep 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $31.46 | n/a | 1 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $4.69 | n/a | 3 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $1.09 | n/a | 2 | Jul 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $59 → $55 | $62.16 | n/a | 45 | May 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $33.58 | n/a | 10 | Dec 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $86.55 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $11.37 | n/a | 6 | Aug 23, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $312 → $322 | $254.81 | n/a | 2 | Aug 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $29 | $1.08 | n/a | 1 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $35 → $30 | $5.75 | n/a | 6 | Feb 4, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $198 → $230 | $220.96 | n/a | 7 | Jan 28, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $169.39 | n/a | 1 | Apr 14, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $48 | $180.16 | n/a | 1 | Mar 5, 2013 |
Entera Bio
Nov 10, 2026
Maintained: Buy
Price Target: $11
Current: $3.24
Upside: +239.51%
ANI Pharmaceuticals
Nov 5, 2026
Reiterated: Buy
Price Target: $119 → $121
Current: $67.88
Upside: +78.26%
Vera Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $76 → $66
Current: $30.60
Upside: +115.69%
Amgen
Nov 4, 2026
Reiterated: Hold
Price Target: $378 → $435
Current: $465.15
Upside: -6.48%
Pfizer
Nov 4, 2026
Reiterated: Buy
Price Target: $31 → $33
Current: $29.24
Upside: +12.86%
Travere Therapeutics
Nov 3, 2026
Reiterated: Buy
Price Target: $89 → $78
Current: $51.64
Upside: +51.05%
AbbVie
Nov 1, 2026
Reiterated: Buy
Price Target: $288 → $322
Current: $293.31
Upside: +9.78%
Insmed
Nov 1, 2026
Reiterated: Buy
Price Target: $205 → $201
Current: $116.08
Upside: +73.16%
Merck & Co.
Oct 29, 2026
Reiterated: Buy
Price Target: $170 → $171
Current: $148.72
Upside: +14.98%
Eloxx Pharmaceuticals
Oct 27, 2026
Reiterated: Buy
Price Target: $43 → $40
Current: $12.80
Upside: +212.50%
Oct 15, 2026
Reiterated: Buy
Price Target: $47
Current: $15.60
Upside: +201.38%
Oct 6, 2026
Reiterated: Buy
Price Target: $287
Current: $282.13
Upside: +1.73%
Aug 21, 2026
Reiterated: Buy
Price Target: kr 38.00
Current: kr 10.82
Upside: +251.20%
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $9
Current: $1.51
Upside: +496.03%
Aug 20, 2026
Reiterated: Buy
Price Target: $11
Current: $5.04
Upside: +118.47%
Aug 16, 2026
Reiterated: Buy
Price Target: $43
Current: $21.74
Upside: +97.79%
Aug 13, 2026
Reiterated: Buy
Price Target: $11
Current: $5.66
Upside: +94.35%
Aug 12, 2026
Reiterated: Buy
Price Target: $37 → $25
Current: $3.69
Upside: +578.43%
Jul 1, 2026
Reiterated: Buy
Price Target: $5 → $3
Current: $3.59
Upside: -16.43%
Jun 25, 2026
Reiterated: Buy
Price Target: $15
Current: $10.80
Upside: +38.95%
Mar 20, 2026
Reiterated: Buy
Price Target: $8
Current: $2.86
Upside: +179.72%
Jul 13, 2025
Reiterated: Buy
Price Target: $6 → $7
Current: $1.16
Upside: n/a
May 29, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.13
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: €9.00
Current: €11.02
Upside: n/a
May 6, 2024
Reiterated: Hold
Price Target: n/a
Current: $10.90
Upside: n/a
Jun 15, 2023
Reiterated: Buy
Price Target: $50 → $26
Current: $4.15
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $89.90
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $1,412.05
Upside: n/a
Jul 22, 2022
Rated: Hold
Price Target: n/a
Current: $15.86
Upside: n/a
Jun 27, 2022
Reiterated: Buy
Price Target: $49
Current: $133.90
Upside: n/a
Jun 21, 2022
Reiterated: Buy
Price Target: $15
Current: $6.97
Upside: n/a
Jun 17, 2022
Rated: Hold
Price Target: $27
Current: $16.48
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: $36
Current: $46.16
Upside: n/a
May 24, 2022
Reiterated: Buy
Price Target: $20 → $10
Current: $1.50
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $52
Current: $102.97
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $738
Current: $920.51
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $6
Current: $40.67
Upside: n/a
May 22, 2022
Initiated Coverage: Buy
Price Target: $135
Current: $48.10
Upside: n/a
May 22, 2022
Initiated Coverage: Hold
Price Target: $265
Current: $550.63
Upside: n/a
May 4, 2022
Reiterated: Hold
Price Target: $95
Current: $168.91
Upside: n/a
Sep 21, 2021
Reiterated: Buy
Price Target: $58
Current: $26.23
Upside: n/a
May 7, 2021
Reiterated: Buy
Price Target: $37
Current: $31.46
Upside: n/a
Jul 10, 2019
Initiated Coverage: Hold
Price Target: n/a
Current: $4.69
Upside: n/a
Jul 10, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $1.09
Upside: n/a
May 29, 2019
Reiterated: Hold
Price Target: $59 → $55
Current: $62.16
Upside: n/a
Dec 13, 2018
Upgraded: Buy
Price Target: n/a
Current: $33.58
Upside: n/a
Nov 27, 2017
Initiated Coverage: Buy
Price Target: $19
Current: $86.55
Upside: n/a
Aug 23, 2017
Upgraded: Hold
Price Target: n/a
Current: $11.37
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $312 → $322
Current: $254.81
Upside: n/a
Oct 26, 2015
Rated: Buy
Price Target: $29
Current: $1.08
Upside: n/a
Feb 4, 2015
Downgraded: Sell
Price Target: $35 → $30
Current: $5.75
Upside: n/a
Jan 28, 2015
Reiterated: Buy
Price Target: $198 → $230
Current: $220.96
Upside: n/a
Apr 14, 2014
Reiterated: Buy
Price Target: n/a
Current: $169.39
Upside: n/a
Mar 5, 2013
Initiated Coverage: Buy
Price Target: $48
Current: $180.16
Upside: n/a